Percutaneous intervention of old degenerated saphenous vein grafts

International Journal of Cardiovascular Interventions

Volumn 4, Issue 4, 2001, Pages 187-194

  Silva, Jose A ^a   White, Christopher J ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Intervention; Thrombus; Vein graft

Indexed keywords

ABCIXIMAB; ADENOSINE; CALCIUM CHANNEL BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; NITROPRUSSIDE SODIUM; PLACEBO; VERAPAMIL;

ANGIOGRAPHY; ARTIFICIAL EMBOLISM; ATHERECTOMY; ATHEROSCLEROSIS; BLOOD CLOT LYSIS; BYPASS SURGERY; CATHETER; CLINICAL TRIAL; CORONARY STENT; DEGENERATION; GRAFT FAILURE; GRAFT OCCLUSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; REVIEW; SAPHENOUS VEIN GRAFT; SIDE EFFECT; THROMBECTOMY; VASOSPASM;

EID: 0035567084     PISSN: 14628848     EISSN: None     Source Type: Journal    
DOI: 10.1080/14628840127767     Document Type: Review

References (49)

1. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth cell proliferation
2. Rapidly progressive atherosclerosis in aortocoronary saphenous vein grafts. Possible immunemediated disease
3. Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: Ten years' experience
4. Morphology of saphenous vein-coronary artery bypass grafts: Seven to 116 months after surgery
5. Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein grafts with intracoronary angioscopy in patients with unstable angina
6. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5065 grafts related to survival and reoperation in 1,388 patients during 25 years
7. Reoperation for coronary atherosclerosis. Changing practice in 2509 consecutive patients
8. Reoperation for coronary artery disease. 10 Years of clinical follow-up
9. Balloon angioplasty for the treatment of lesions in saphenous vein grafts
10. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial: Coronary Angioplasty Versus Excisional Atherectomy Trial
11. Late myocardial ischemic events after saphenous vein graft intervention - Importance of initially 'nonsignificant' vein graft lesions
12. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality
13. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions
14. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts
15. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts
16. Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents
17. Direct coronary stenting without predilation
18. Direct coronary stenting without balloon predilatation in acute coronary syndromes
19. Comparative results of transluminal extraction coronary atherectomy in saphenous vein grafts lesions with and without thrombus
20. Preliminary experience with the POSSIS coronary AngioJet Rheolytic thrombectomy catheter in the VEGAS I pilot study
21. A randomized prospective multicenter study comparing intracoronary urokinase to rheolytic thrombectomy with the Possis AngioJet catheter for intracoronary thrombus: Final result of the VEGAS 2 Trial
22. Mechanisms for hemolysis by ultrasonic cavitation in the rotating exposure system
23. Bubble cycling as the explanation of the promotion of ultrasonic cavitation in a rotating tube exposure system
24. Percutaneous transluminal therapy of occluded saphenous vein grafts: Can the challenge be met with ultrasound thrombolysis?
25. Intracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes
26. Efficacy of adjunctive thrombolytic therapy in percutaneous transluminal coronary angioplasty
27. Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts
28. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary artery stents in acute myocardial infarction
29. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts
30. Reduction of complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology
31. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention
32. Treatment of no-reflow in degenerated saphenous vein graft interventions: Comparison of intracoronary verapamil and nitroglycerin
33. Features and outcome of no-reflow after percutaneous coronary intervention
34. The 'no-reflow' phenomenon following temporary coronary occlusion in the dog
35. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions
36. Reversal of 'no-reflow' during vein graft stenting using high velocity boluses of intracoronary adenosine
37. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: Initial human clinical experience
38. Rapid reversal of no-reflow using abciximab after coronary device intervention
39. Percutaneous revascularization of an extensively diseased saphenous vein bypass graft with a saphenous vein-covered Palmaz stent
40. Total reconstruction of a diseased saphenous vein graft by means of conventional and autologous tissue-coated stents
41. Autologous vein graft-coated stents for the treatment of thrombus-containing coronary artery lesions
42. Phosporylcholine coated stents: Angiographic and morphometric assessment in porcine coronary arteries
43. Clinical and angiographic follow-up after autologous vein graft-coated stent implantation
44. Stents coated by an autologous arterial graft: The first application in human coronary arteries
45. Autologous vein graft-coated stent for the treatment of coronary artery disease: Immediate results after percutaneous implantation in humans
46. Immediate results and dilatation effect of the vein-covered Palmaz-Schatz stent assessed by intravascular ultrasound
47. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system
48. Recognition of the importance of embolization in atherosclerotic vascular disease